Avricore Health (AVCRF) Total Non-Current Liabilities (2016 - 2025)
Avricore Health (AVCRF) reported Total Non-Current Liabilities of -$77445.3 for Q4 2025, down 108.75% quarter-over-quarter from $885281.6 in Q4 2020.
Avricore Health (AVCRF) Total Non-Current Liabilities (2016 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 6 years of Total Non-Current Liabilities data on file, last reported at -$77445.3 in Q4 2025.
- Total Non-Current Liabilities for Q4 2025 came in at -$77445.3, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$77445.3 (changed N/A YoY), and the FY2025 annual result was -$77297.9, changed N/A from the prior year.
- Total Non-Current Liabilities slipped to -$77445.3 in Q4 2025 per AVCRF's latest filing, from $885281.6 in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at -$77445.3 in Q4 2025 and troughed at -$77445.3 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 5.45 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Avricore Health | - | - | - | -77,445.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -77,445.32 |
| Dec 31, 2020 | 885,281.57 |
| Dec 31, 2019 | 494,237.38 |
| Dec 31, 2018 | 238,073.69 |
| Dec 31, 2017 | 237,787.01 |
| Dec 31, 2016 | 267,897.44 |